眼鏡市場

The secondary research process involved comprehensive analysis of regulatory databases, industry standards organizations, peer-reviewed medical journals, and authoritative health and trade institutions. Key sources included the US Food & Drug Administration (FDA) Center for Devices and Radiological Health, European Medicines Agency (EMA) Medical Device Regulation (MDR), International Organization for Standardization (ISO 12870 for ophthalmic optics and ISO 18369 for contact lenses), World Health Organization (WHO) World Report on Vision, Centers for Disease Control and Prevention (CDC) Vision Health Initiative, National Eye Institute (NEI/NIH), American National Standards Institute (ANSI Z80 standards), Federal Trade Commission (FTC) Eyeglass and Contact Lens Rule compliance data, and the Vision Council of America. International trade data was gathered from Euromonitor International, Euromed, and national statistics offices of key markets including Germany (Federal Statistical Office), France (INSEE), Italy (ISTAT), China (National Bureau of Statistics), and India (Ministry of Commerce and Industry). These sources were utilized to collect product safety standards, vision impairment prevalence statistics, regulatory approval pathways for contact lenses and medical device classifications, material standards for frames and lenses, distribution channel metrics, and competitive intelligence across prescription glasses, sunglasses, contact lenses, and protective eyewear segments.

In the primary research process, qualitative and quantitative insights specific to the global eyewear value chain were obtained by interviewing supply-side and demand-side stakeholders. Supply-side sources encompassed Chief Executive Officers, Vice Presidents of Product Innovation, Heads of Regulatory Affairs, and Commercial Directors from prominent frame manufacturers (such as EssilorLuxottica, Safilo Group, Marcolin, Kering Eyewear, Marchon Eyewear, and Fielmann AG), ophthalmic lens manufacturers (such as Zeiss, Hoya Corporation, and Shamir), contact lens producers, raw material suppliers (acetate, titanium, and bio-based materials), and OEM/ODM partners who specialize in smart eyewear technology. The demand-side sources included licensed optometrists and ophthalmologists, optical chain medical directors, independent dispensing opticians, procurement heads from multi-brand optical retailers, sunglass specialty store buyers, e-commerce platform merchandising leads, and department store eyewear category managers. Primary research has confirmed pipeline timelines for smart eyewear and sustainable materials, validated product segmentation across prescription, sunglass, and contact lens categories, and gathered insights on omnichannel distribution strategies, prescription fulfillment dynamics, regional pricing architectures, and consumer preference shifts toward customization and virtual try-on technologies.

Primary Respondent Breakdown:

By Designation: C-level Primaries (40%), Director Level (25%), Others (35%)

By Region: North America (40%), Europe (28%), Asia-Pacific (24%), Rest of World (8%)

Global market valuation was derived through systematic revenue mapping and unit volume analysis across optical retail channels. The methodology included:

Identification of over 50 main manufacturers in North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa, including frame producers, lens manufacturers, and contact lens suppliersProduct mapping encompasses prescription spectacles (spectacle lenses and frames), sunglasses (fashion and corrective), contact lenses (daily disposables, extended wear, and specialty), reading glasses, and safety/protective eyewearA material segmentation analysis that encompasses sustainable wood/bio-based alternatives, metal (titanium, stainless steel, monel), and plastic (acetate, TR90)Analysis of annual revenues for eyewear portfolios, as reported and modeled, disaggregated by distribution channel (optical stores, online retail, department stores, and independent retailers)

Coverage of manufacturers and brands representing 75-80% of global market share in 2024

Extrapolation using bottom-up (procedure volume × average selling price by country, stratified by prescription complexity and lens type) and top-down (manufacturer revenue validation and retail audit data) approaches to derive segment-specific valuations for product type, material composition, end-user demographics, and regional distribution dynamics

Integration of trade association shipment data, retail point-of-sale tracking, and ophthalmic survey statistics to refine market share allocations across luxury, mid-market, and value-tier segments